Substrate specificity of vitamin K epoxide reductase C1

Please copy the URL and add it into your RSS Feed Reader.

Hamostaseologie 2009; 29(S 01): S116
DOI: 10.1055/s-0037-1621505

Communication

Schattauer GmbH

Substratspezifität der Vitamin-K-Epoxid-reduktase C1

Authors

M. Marinova

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
M. Watzka

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
P. Westhofen

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
M. Hass

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
D. Lütjohann

²Institute of Clinical Biochemistry and Pharmacology, University Clinic Bonn, Germany
J. Oldenburg

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany

Publication Date:
04 January 2018 (online)

References
1 Rost S, Fregin A, Ivaskevicius V. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427 6974 537-541.

Reference Link Ris
Crossref PubMed Search in Google Scholar
2 Oldenburg J, Bevans CG, Müller CR, Watzka M. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. Antioxid Redox Signal 2006; 8: 347-353.

Reference Link Ris
Crossref PubMed Search in Google Scholar